This report presents data from the 2002 through 2014 National Surveys on Drug Use and Health (NSDUHs) for trends in people’s perceptions of great risk of harm associated with the use of cigarettes, alcohol, and specific illicit drugs and the perceived availability of substances. The data are presented for the...
Search Results
This report describes changes in the 2014 and 2015 NSDUHs that were designed to increase the efficiency of data collection and processing and to improve the quality of the data collected. In 2014, changes were made in the sample sizes allocated to each state and to different age groups in...
This report presents an evaluation of the coverage, overlap, biases, strengths, and weaknesses of three sources of data on the receipt of specialty substance use treatment: the National Survey on Drug Use and Health (NSDUH), the National Survey of Substance Abuse Treatment Services (N-SSATS), and the Treatment Episode Data Set...
This report describes the results of data collection efforts conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Centers for Disease Control and Prevention (CDC) related to the behavioral health (mental health and substance use) of residents of the Gulf Coast affected by the Deepwater Horizon...
The 27 national maps presented here show the 2010-2012 National Survey on Drug Use and Health (NSDUH) estimates for 363 substate regions. Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI)...
This spotlight presents 2012 National Surveys on Drug Use and Health (NSDUH) data on serious thoughts of suicide in the past year among adults aged 18 or older by whether the person with serious thoughts of suicide has also used illicit drugs in the past year.
This report uses 2013 National Survey on Drug Use and Health (NSDUH) to assess the prevalence of substance use and mental disorders among those aged 12 or older, adolescents aged 12 to 17, and adults aged 18 or older and the receipt of treatment/services for behavioral health issues. The 2013...
This National Survey on Drug Use and Health (NSDUH) short report shows inhalant use by adolescents 12 to 17 years old. It also looks at inhalant use by gender, race, region of the country, metro area, past year use and days used.
This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits by status of follow-up care for drug-related suicide attempts involving antidepressants among adolescents aged 12 to 17 from 2008 to 2010.
This short report uses data from the 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs), the 2010 Treatment Episode Data Set (TEDS), the 2010 National Survey of Substance Abuse Treatment Services (N-SSATS), and the 2011 Drug Abuse Warning Network (DAWN) to present facts about adolescent substance use...
This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of phamaceuticals by gender among older adolescents age 12 to 17 from year 2010.
This issue of the National Survey on Drug Use and Health (NSDUH) Report presents combined 2002 to 2010 data to examine substance use patterns among
This spotlight report describes the risks of combining the drug Ecstasy (also known as MDMA or methylenedioxymethamphetamine) with alcohol. For emergency department patients aged 20 and younger, it provides the number of emergency department visits that involved Ecstasy, and the percentage of Ecstasy-related visits that involved alcohol for the years...
This report uses 2002 to 2010 National Survey on Drug Use and Health (NSDUH) to assess the average number of adolescents aged 12 to 17 using substances for the first time per day for the year as a whole and for each month of the year. Substances examined include alcohol...
This report uses 2002 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past month alcohol use, cigarette use, marijuana use, and nonmedical use of prescription-type drugs among Hispanic youth aged 12 to 17. Results are shown for each substance by year, Hispanic subgroups, whether born in...